Vaxfab Enterprises Limited appointed Mrs. Dhruvi Patel as its new Company Secretary and Compliance Officer effective October 16, 2026. The appointment follows the resignation of Mrs. Neha Rishabh Bardia, who stepped down from the position citing personal reasons.

Board approval and transition details

The Board of Directors approved the appointment based on the recommendation of the Nomination and Remuneration Committee during a meeting held on October 16, 2026. The session commenced at 4:30 pm and concluded at 5:00 pm. Concurrently, the Board accepted the resignation letter tendered by Mrs. Neha Rishabh Bardia. She will be relieved from her duties upon the closing of working hours on the same date.

Profile of the incoming officer

Mrs. Dhruvi Patel is a qualified Company Secretary and an Associate Member of the Institute of Company Secretaries of India (ICSI) with membership number ACS-81388. Her professional background includes extensive experience in corporate laws, secretarial compliances, corporate governance, regulatory affairs, board management, and compliance functions.

Regulatory disclosures

The company informed BSE Limited and The Calcutta Stock Exchange Limited regarding these changes in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosures included details required under Part A, Para A of Schedule III of the SEBI Listing Regulations, 2015, and SEBI Circular No SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

The transition ensures continuity in the company's secretarial and compliance functions under the new leadership structure.

Vaxfab Enterprises Limited's board approved a fund raise of up to ₹45 crore through a rights issue of equity shares. The decision was taken during the meeting held on October 1, 2026, at the company's registered office in Ahmedabad.

The approved proposal involves issuing equity shares with a face value of ₹10 each to existing shareholders on a rights basis. The total aggregate amount for this issuance will not exceed ₹45 crore. This move narrows down the earlier broad agenda which included multiple instruments like QIPs and FCCBs.

Rights issue specifics

The board authorised the issuance subject to regulatory approvals under SEBI (ICDR) Regulations, 2018 and the Companies Act, 2013. The specific price and entitlement ratio for the rights issue will be decided by the Board or a newly formed Rights Issue Committee. The record date for eligibility will be notified subsequently.

To manage the process, the board constituted a Rights Issue Committee comprising:

• Ravindra Ashokbhai Joshi (Chairman)
• Jinang Dineshkumar Shah (Member)
• Juhi Sawajani (Member)

This committee is empowered to appoint intermediaries and execute all necessary acts for the completion of the rights issue.

Meeting details and compliance

The board meeting commenced at 4:00 pm and concluded at 4:30 pm. In line with previous disclosures, the trading window for designated persons had closed on September 25, 2026, and remained closed until 48 hours after the meeting's conclusion.

The intimation regarding the outcome was filed with BSE Limited and The Calcutta Stock Exchange Limited under Regulation 30 of SEBI (LODR) Regulations, 2015.